期刊文献+

非特异性免疫药物结合中药对激素抵抗性哮喘患者Th1/Th2细胞因子的影响 被引量:3

Effect and balancc of Thl/Th2 cytokines in steroid resistant asthma by non-specific immune drugs with traditional chinese medicine
下载PDF
导出
摘要 目的探讨非特异性免疫药物结合中药治疗激素抵抗性哮喘患者T淋巴细胞表达Th1/Th2细胞因子(IL-4、IFN-γ)之间的平衡以及临床疗效。方法 60例确诊为SRA患者,随机分为2组。非特异性+中药治疗组(治疗组)30例和非特异性治疗组(对照组)30例,两组均连续治疗10d为1个疗程,共3个疗程。观察2组治疗疗效、IL-4、IFN-γ的变化。结果治疗组总有效率93.3%明显高于对照组76.6%(P<0.05)。治疗组IL-4较对照组明显下降(P<0.05),治疗组IFN-γ较对照组明显提高(P<0.05)。结论非特异性免疫药物结合中医治疗SRA有较好的疗效,可显著纠正Th1/Th2表达细胞因子功能的失衡,减轻患者的变态反应性炎症。 Objective To study the effect and balancc of Thl /Th2 cytokines of steroid in resistant asthma(SRA) by non-specific immune drugs with traditional chinese medicine(TCM).Methods 60 cases with SRA were randomly divided into non-specific + medicine treatment group(experimental group) 30 cases and non-specific treatment group(the control group.) 30 cases,two groups were treated continuously for 10 days as a course of treatment,a total of 3 courses.IL-4、 IFN-γ were measured befcore and after treatment.Results A total effective rate in treatment group 93.3% were higher than 76.6% in the control group.(P0.05) The IFN-γin treatment group after treatment compared with control group had significantly improved(P0.05).The IL-4 after treatment compared with control group were significantly lower(P0.05);Conclusion TCM combination with The non-specific immune drugs have good effect and the functions of Th1 and Th2 cell of cytokines expressionmay be rebalanced.in patients with SRA.
出处 《中国现代药物应用》 2011年第6期12-13,共2页 Chinese Journal of Modern Drug Application
关键词 支气管哮喘 激素抵抗 非特异性 中药 Asthma Hormone resistance Non-specific Traditional chinese medicine
  • 相关文献

参考文献4

二级参考文献25

  • 1Koh Y I,Choi I S,Kim W Y,et al.Effects of BCG infection on Schultz-Dale reaction,allergen-specific IgE levels,and Th2 immune response in sensitized rats.Korean J Intern Med,2001,16:180-186. 被引量:1
  • 2Romagnani S.The Th2 hypothesis in allergy--"Eppur si muovel!".Allergy Clin Immunol Intern,1998,10:158-165. 被引量:1
  • 3Romagnani S.The role of lymphocytes in allergic disease.J Allergy Clin Immunol,2000,105:399-408. 被引量:1
  • 4Wechsler ME, Israel E. Pharmacogenetics of treatment with leukotriene modifiers. Curr Opin Allergy Clin Immunol,2002,2: 395-401. 被引量:1
  • 5Robert CS, Gordon RB. Omalizumab for Asthma. N Engl J Med, 2006,354:2689-2695. 被引量:1
  • 6Barnes P J, Wooleoek AJ. Difficult asthma. Eur Respir J, 1998, 12:1209-1218. 被引量:1
  • 7Xu Q, Leung DY, Kisich KO. Serine arginine-rich protein p30 directs alternative splicing of glucocorticoid receptor pre-mRNA to glucocorticoid receptor-β in neutrophils. J Biol Chem, 2003, 278:27112-27118. 被引量:1
  • 8Cho YJ, Lee KE. Decreased glueocortieoid binding aginity to glucocorticoid receptor is important in the poor response to steroid therapy of older-aged patients with severe bronchial asthma. Allergy Asthma Proc, 2003,24 : 353-358. 被引量:1
  • 9Evangelia Charmandari, Annaswamy Raji, et al. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance:The importance of the C terminus of hGR LBD in conferring transactivational activity. J Clin Endocrinol Metab, 2005,90 : 3696-3705. 被引量:1
  • 10Bamberger CM, Bamberge AM, de Castro M, et al. Glucocorticoid receptor bata potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest, 1995,95: 2435- 2441. 被引量:1

共引文献44

同被引文献35

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部